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Multiple deficiencies of mitochondrial DNA-and nuclear-encoded subunits of respiratory NADH dehydrogenase detected with peptide-and subunit-specific antibodies in mitochondrial myopathies
Introduction
It spans the mitochondrial inner membrane and oxidizes NADH Mitochondrial (encephalo)myopathies are a heteroge neous group of disorders affecting predominantly skeletal muscle and the central nervous system. A defect in the mitochondrial energy metabolism is thought to be the primary cause of disease. One of the respiratory chain This large multimeric protein consists of at least 41 sub units (review [3] ), including seven (called ND) subunits that are encoded in the mitochondrial genome [4, 5] .
Antibodies against Complex I subunits are very useful for studying the molecular basis of mitochondrial enenzymes that is frequently found deficient in various tiscephalomyopathies. Polyclonal antibodies against purified sues of patients is NADH-ubiquinone oxidoreductase beef heart Complex I have been previously shown to react (NADH dehydrogenase or Complex I, EC 1.6.99.3) [1, 2] . with only approximately 15 subunits ol the enzyme in human mitochondria. The use of these antibodies with skeletal mitochondrial proteins from myopathy patients showed a generalized reduction of all cross-reacting poly peptides, in some cases with a disproportionate and severe The ND not detected by these antibodies. In brackets arc given the amino acid numbers corresponding to Anderson et al. [12] . The peptides were extended with L-norleucine (Nle) and S-acetylthioacetyl (SATA) at the amino-terminus for determination of the peptide-carricr ratio and coupling-procedures, respectively [14] .
Antibodies against synthetic peptides corresponding to the C-or N-terminal regions of the human mtDNA-encoded subunits have been previously used to identify the corresponding polypeptides by immunoprécipitation assays [4, 5, 7, 8] and, occasionally, by immunoblotting [9] . Anti bodies against peptides of predicted antigenic sequences can recognize epitopes on the whole protein [10, 11] . Since the hydrophobic ND subunits are very difficult to purify and have a low immunogenicity, we have raised antibodies against a few chemically synthesized peptides correspond ing to predicted epitopes. In this paper, we describe the preparation and characterization of antibodies against sev eral peptides of human mitochondrial NADH dehydro genase subunits ND4, ND5 and ND6, and the use of these antibodies, as well as of antibodies specific for other subunits of the enzyme, for the molecular analysis of 
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(>5 Complex I defects in human mitochondrial myopathies. Multiple deficiencies of mtDNA-and nuclear-encoded subunits of this enzyme complex have been detected in myopathy patients, and shown to correlate with the sever ity of the enzyme defect.
Immunization of rabbits

Materials and methods
Selection and synthesis of peptides
The reported sequence of the human mitochondrial genome [12] was computer analyzed using the program PEPPLOT [13] . Criteria for selection of linear epitopes were hydrophilicity, surface probability, flexibility, high /3-turn and low «-helix or /3-sheet propensity [11] . The amino acid sequences of the selected peptides for ND4, ND5 and ND6 are shown in Table 1 ; their position in each subunit is shown in Fig. 1 . Several candidate epitopes of ND4 were selected. The C-terminal peptide previously used by Mariottini et al. [8] , even though it was not a predicted epitope by the criteria mentioned above, was synthesized for purpose of comparison. Only one internal epitope of ND5 and ND6 was chosen. For ND6, this was the only candidate epitope not used previously by Chomyn et al. [5] . The peptides were custom synthesized by Dr. G.I. Tesser (Laboratory of Organic Chemistry, University of Nijmegen, The Netherlands) by solid phase peptide chemistry. The peptides were extended with L-norleucine (Nie) and S-acetylthioacetyl (SATA) at the N-terminus for determination of the peptide-carrier ratio and coupling-procedures, respectively [14] .
FPLC, FAB mass spectra and amino acid analysis
Peptides were analyzed by reversed-phase chromatogTwo rabbits were injected with each antigen at 2 -3 week intervals. Each rabbit received a peptide-carrier pro tein conjugate mixed in a 1:1 (v /v ) ratio with the Freund's adjuvant system (complete, FCA or incomplete, FIA, Difco). Conjugates of ND4~I3 and ND4-C were also tested with the Ribi adjuvant system (RAS, Sanbio). The admin istration of adjuvant preparations was as follows: FCA (1 mg conjugate, total volume 2 ml) intradermally at 20 sites on the back of the animal; FIA (0.5 mg conjugate, total volume 1 ml) intramuscularly and subcutaneously; (first dose 1 mg conjugate, thereafter 0.5 mg, each total volume 1 ml) at multiple places according to suggestions of the manufacturer. Blood samples were taken before the first injection (preimmune serum) and either 2 weeks after or immediately before the booster injections. The sera were prepared and stored at -20°C. Before use, they were made free of antibodies against the carrier proteins by passing them twice over a column of carrier protein conju gated to CNBr-activated Sepharose (Pharmacia/LKB). yGlobulins were isolated by fractionating the sera over a Protein A Sepharose column (Pharmacia/LKB).
The rabbit antibodies against the 24 kDa subunit of bovine Complex I were raised using the purified protein over-expressed in Escherichia coli (Wilks, P.E., Medd, S.M. and Walker, I.E., unpublished data). The adenine nucleotide translocase (ANT) was isolated from bovine heart mitochondria by subsequent chromatography [15] and electrophoresis [16] . The ATPase (Complex V) was purified from human heart mitochondria by blue native electrophoresis [17] . Antibodies were raised in rabbits by inoculation of the purified proteins into the popliteal lymph nodes according to Sigel et al. [18] . The antibodies against the ATPase react mainly with the /3-subunit in an immunoblot assay (results not shown). The antibodies against raphy using a PepRPC HR 5 /5 column (Pharmacia/LKB) the bovine Complex I holo-enzyme and the ND1 subunit and a continuous gradient of acetonitrile (0-40% , v /v ) in 0.1% (v /v ) trifluoroacetic acid created by an FPLC system (Pharmacia/LKB). FAB mass spectra of collected peak fractions were analyzed by Dr. G. van de Werken (Na tional Institute of Health, Bilthoven, The Netherlands). The samples were hydrolyzed with 6 M HC1 for 1 h at 150°C or 18 h at 120°C in vacuum hydrolysis tubes (Pierce). The amino acid content of the hydrolysates was determined with an Alpha-Plus amino acid analyzer (Pharmacia/LKB).
of Neurospora crassa were kind gifts from Dr. U. Har nisch (Department of Biochemistry, University of Düssel dorf, Germany) and Dr. S. Werner (Department of Physio logical Chemistry, University of Munich, Germany), re spectively. The former showed a reaction with approxi mately 10 subunits of Complex I preparations from bovine and human heart tissue (results not shown). The latter were raised against a highly conserved peptide which has 12 14 amino sequence [19] .
with the human 2.3. Coupling of peptides to carrier proteins 2.5. Enzyme-linked immunosorbent assay (ELISA) Peptides were coupled to the carrier proteins bovine serum albumin (BSA), myoglobin (MYO) or ovalbumin (OA, all from Sigma) with 6-maleimidohexanoic acid Nhydroxysuccinimide ester (MHS, Pierce) according to Schielen et al. [14] , except that 6-maleimidobenzoic acid JV-hydroxysulfosuccinimide ester (Sulfo-MBS, Pierce) was used as a linker in some cases.
Antibody titers were determined by ELISA assays es sentially as described by GeerKgs et al. [20] , using the peptides coupled with a different linker to a different carrier protein as coating antigens, in order to exclude any cross reactions. The titer is defined as the reciprocal of the serum dilution giving an ELISA-signal above background (no serum addition), equivalent to twice the -sum of the mean background and its-standard deviation. The antibod ies raised against the carrier and the linking part were also assayed. The specificity of each reaction was investigated by testing the serum sample after a preincubation with the corresponding peptide.
Labeling and immunoprécipitation of mitochondrial translation products
HeLa cells were labeled for 2 h with [35S]methionine (20-50 ¿iCi/m l; 1000-1500 Ci/m m ol) in the presence of emetine, an inhibitor of cytoplasmic protein synthesis, at 100 yu.g/ml, and at a cell concentration of 2 • 106/m l [21] , whereafter the mitochondrial fraction was isolated [7] . Immunoprécipitation was carried out using a SDS lysate of Seven patients were selected for this study based upon extensive biochemical analysis which pointed towards a Complex I deficiency. A brief overview of some clinical features and laboratory data is presented in Table 2 . Con trol specimens were considered those in which a mitochon drial defect had been excluded by normal substrate oxida tion rates and individual enzyme measurements, as previ ously described [24] .
P5 and P7 are patients diagnosed in our hospital with the MELAS syndrome; both carry an A to G transition at position 3243 in approximately 50% of their skeletal mus cle mtDNA (Van Oost, B.A., personal communication). All other patients and controls lack this as well as other known mtDNA mutations associated with mitochondrial myopathies or respiratory chain defects [25] . P5 and P6 are previously described patients [26, 27] . this fraction as described previously [8] , except that 80 jug of mitochondrial suspension (15 • 104 cpm) was used in each experiment. For each reaction either 8.5 ¡x\ of anti serum or 85 /mg of the y-globulin fraction was used. Inhibition by peptides was tested by adding to the serum 5 ¡x\ peptide solution in dimethylsulfoxide (DMSO) at 1 m g/m l. Where stated, 5 /¿I DMSO was used as a control. The final immunoprecipitates were run on a 15-20% (w /v ) exponential gradient SDS polyacrylamide gel [22] and prepared for fluorography [23] . The previously de scribed antibodies against ND4-C(451-459), ND5-N(l-7), ND5-C(598-603) and ND6-Ij(74-84) were used for refer ence purposes [4, 5] .
Enzyme measurements
The activities of the rotenone-sensitive NADHubiquinone-1 oxidoreductase (Complex I), succinate-cytochrome-c oxidoreductase (Complex II-III), cytochrome-c oxidase (Complex IV) and citrate synthase were measured in 600 X g supernatant or, where stated, in mitochondria of homogenized skeletal muscle as described previously [24] . The activities in 600 X g supernatants from fresh biopsy muscle were first normalized for citrate synthase activities. All activities are expressed as a percentage of the mean of controls. Ubiquinone-1 was a gift from Hoffman-La Roche, Basel, Switzerland.
Patients and controls
Specimens of the quadriceps muscle were removed by biopsy from patients suspected to have a defect in oxida tive phosphorylation. From patients PI and P6 also au topsy material removed within 1 h after death was studied.
SDS-polyacrylamide gel electrophoresis and western blotting
Mitochondrial proteins, isolated by differential centrif ugation of homogenized skeletal muscle specimens, were PBST. The ECL kit (Amersham) was used for detection of bound antibodies.
Rabbit antibodies raised against ANT or the ATPase complex were used as an internal standard for mitochon drial protein recovery at a dilution of 1:2000. Quantitation of the blots was carried out by scanning the films with a LKB laser densitometer.
Tabic 3
Antibody titers against peptides, carrier proteins or linkers 3. Results
Analysis and coupling of peptides
Reversed phase chromatography showed that the pep tides were pure to the extend of 70% or more (results not shown). Mass spectrometric analysis of the major peaks confirmed the expected mass of the peptides, indicating complete removal of the protecting groups. The crude peptide preparations were coupled to carrier proteins with out further purification, since only the full-length products were expected to contain the SATA group necessary for coupling [14] . Coupling ratios were determined by amino acid analysis of the conjugates comparing the amount of L-norleucine (specific for the peptides) with that of amino acids found only in the carrier proteins. Coupling ratios were 3-10 and 7-20 peptides per OA or BSA carrier molecule, respectively. The maximum available free amino groups in both carrier proteins are 10 and 27, respectively [113. 
Antibody production
Antibody titers reached maximum values after three immunizations. All rabbits responded to the conjugates used for immunization. In the first experiments, the RAStreated animals showed antibody titers that were lower, by a factor 10 to 40, than those of FCA/FIA-treated animals ( Table 3 ). The linkers (MHS or sulfo-MBS) produced only low levels of antibodies in all animals, except for those immunized with ND4-I5. MHS has already been shown to be poorly immunogenic [30] , All subsequent experiments were done with the sera from the FCA/FIA-treated ani mals. 
ND4-I kDa 97
Immunoprécipitation capacity of subunit-specific anti bodies
The results of the immunoprécipitation studies are shown in Fig. 2 . Lane M shows the pattern of HeLa cell mitochondrial translation products labeled with [35S]methionine in the presence of emetine. Note the migration of ND6 as a doublet in the exponential gradient system used here [22] (see Discussion). It appears from Fig. 2 that only antibodies against ND4-I5 and ND4-C were capable of immunoprecipitating the labeled ND4 subunit, in a reac tion inhibited by the specific peptide. This immunoprécip itation was as effective as that observed with the ND4-C antiserum described by Chomyn et al. [4] (results not shown). The other ND4 peptide-specific antibodies were negative in Also the antibodies against ND5-I and ND6-I3 precipi tated the ND5 and ND6 subunit, respectively, the reaction with each protein being inhibited by the corresponding peptide. The ND5 subunit could be visualized only after long exposure of the film. This resulted in some back ground of non-specific bands not inhibited by the specific peptide (Fig. 2) . Antibodies against C-and N-terminal peptides of ND5 showed no reaction (results not shown).
Our ND6-I3 peptide antibodies precipitated ten times more ND6 than the ND6-I, antiserum, which has been used previously to identify ND6 as a NADH dehydro genase subunit [5] . The immunoprecipitated ND6 migrated in the gel as a doublet as in the original sample (lane M in Fig. 2 ). The higher molecular weight bands in the ND6-I3 ( -pept) lane may be a result of aggregation during the assay [5] . Purified y-globulins gave an identical immuno précipitation pattern as total serum (results not shown). Fig. 3 shows the results of Western blotting experi-SDS-polyacrylamide gel elecments out by using mitochondrial proteins from human and y-globul in-fractions as skeletal peptide-specific antibodies. With the ECL detection system 2 fig of mitochondrial protein per lane was already suffi cient a signal. Total serum gave a very high signal, in part caused by the high levels of carrier proteins (results not shown). Therefore, purified y-globulin-fractions, from which the anti-carrier-antibodies had been removed, were used.
Analysis blotting
It-specific antibodies by Western
The antibodies against ND4-I5 and ND4-C reacted very strongly with a protein of apparent molecular mass of 39 kDa (as estimated from its electrophoretic mobility, rela tive to that of water-soluble marker proteins), the reaction being inhibited by the specific peptide (Fig. 3, first four  lanes) . The molecular mass of this protein is in agreement with that previously reported for bovine and human ND4, on the basis of its electrophoretic mobility in SDS-polyholoenzyme-specific antibodies were used to analyze the acrylamide gels [4, 9, 31] . The difference in size estimate relative to that predicted from the DNA sequence is due to the use, in the experiments cited above, of hydrophilic marker proteins, which bind less SDS than the hydropho bic mitochondrial translation products [8] . The antiserum against ND4-I5, which has 12 of 16 amino acids identical with the homologous bovine sequence, also reacted with a mitochondrial protein from bovine heart of approximately the same molecular mass (results not shown). The other ND4 peptide-specific antibodies were negative even in up to 100-fold lower dilutions (results not shown).
The antibodies against ND5-I and ND6-I3 also showed peptide-specific reactions. The ND5-I-specific antibodies produced two bands in a reaction that could be inhibited by the specific peptide. In particular, they gave a strong reaction with a protein of apparent molecular mass of 51 kDa, and a minor reaction with a protein of a somewhat higher electrophoretic mobility (Fig. 3 , fifth and sixth lane). The 51 kDa protein has the electrophoretic mobility, in an SDS-polyacrylamide gel, expected for the ND5 gene product, the difference from the mass expected for this product (66 kDa) being due to the bias in size estimates which was mentioned above. The minor reaction with the protein moving faster than the '51 kDa' protein could be explained as resulting from a cross-reaction with another mitochondrial protein with a similar or identical ND5-I epitope(s); however, a computer search did not yield a known protein containing a sequence homologous for the amino acid sequence used. The ND6-I3-specific antibodies gave a specific reaction with a protein of apparent molecu lar mass of ~ 8 kDa, as estimated relative to the marker proteins (Fig. 3) . Here, too, the difference in molecular mass from that predicted from the DNA sequence (18.6 kDa) is due to the bias in size estimates introduced by the use of hydrophilic proteins for the standard curve [8] . Both the ND5-I-and ND6-I3-specific antibodies gave a weak reaction in the immunoblot as compared to the ND4 antibodies. Therefore, 10-times less diluted antibodies and also longer exposure times with the ECL system, in the case of ND5, had to be used. This caused the rather high background in lanes ND5-I and ND6-I3 in Fig. 3 . The background in the upper portion of the lanes is most likely caused by biotin-containing proteins reacting with the streptavidin/horseradish peroxidase biotin complex, as shown in lanes A and B, where the primary and, in lane B, also the secondary antibodies, were omitted during the incubations. The molecular weights of the slower-migrating proteins (arrows) are in agreement with those of biotin containing carboxylases, as reported by Robinson et al. [32] .
Immunoblotting of skeletal mitochondrial proteins from myopathy patients with subunit-or holoenzyme-specific an tibodies
The antibodies produced here and other subunit-or quantitative behaviour of the corresponding subunits in the respiratory NADH dehydrogenase of skeletal muscle from mitochondrial myopathy patients exhibiting an enzymatical Complex I deficiency. Fig. 4 shows that antibodies against the bovine Com plex I holoenzyme (panel a) and against the ND1 peptide of Neurospora crassa (panel b) both gave weaker reac tions with mitochondrial proteins from patients P1-P5, as compared to the reactions observed with material from control individuals; patients P6 and P7 were not investi gated with these antibodies. Antibodies against the bovine Complex I holoenzyme gave a specific reaction with ap proximately ten proteins when tested against a Complex I preparation from bovine or human heart tissue (results not shown). Their position is indicated by arrowheads in Fig.  4 , part a. These are probably all encoded in nDNA. The background in the upper portion of the lanes is, again, most likely caused by biotin-containing proteins reacting with the streptavidin/horseradish peroxidase biotin com plex, as shown in Fig. 3 . The bands marked with asterisks in the lower portion of the patient lanes PI, P3 and P4, which have a stronger intensity or a different mobility, as compared to the bands from control individuals migrating at the same positions, are probably degradation products. Note that the strong reaction with a protein of apparent molecular mass of 24 kDa in the patient lanes of Fig. 4 is not the result of a reaction with antibodies against the 24 kDa subunit of Complex I (shown in Fig. 5 ).
The reaction with antibodies against the human ATPase /3 subunit also exhibited a normal intensity in the samples from patients P1-P5, as compared to the controls (Fig. 5,  panel c) , indicating the absence of significant differences in the purity of the mitochondria. Fig. 5 shows that antibodies against the ND4-I5, ND5-I and ND6-I, peptides, as well as antibodies against the purified bovine 24 kDa FeS protein of Complex I, which is encoded in the nuclear genome, gave weaker reactions when tested with material from all seven patients studied, as compared to the reactions with samples from control individuals. This was not caused by differences in the purity of the mitochondria, because, except for patient P4, no large differences were seen among the various samples in the reaction with antibodies against the bovine ANT protein (Fig. 4, bottom) or human ATPase /3 subunit (Fig.  4, panel c) . The strong reduction of ANT in mitochondria from patient P4 may have been caused by an additional deficiency of ANT protein in this patient. Support for this interpretation comes from the observation that the protein cross-reacting with the ND5-I antibodies, which is marked by an asterisk in Fig. 5 , appeared to be present in mito chondria of patient 4 in the same amount as, e.g., in the samples of P5 and P6, which show a good reaction with the ANT-specific antibodies. The possibility of an ANT deficiency in patient P4 is presently under further investi gation.
There is a good correlation between the signal of immunodetected Complex I subunits, as determined by den sitometry, and the activities of Complex I in b mitochondria from different individuals, as shown in the lower part of Fig. 5 . The correlation coefficients for the ND4, ND5, ND6 and 24 kDa subunits, normalized for the ANT signal, were 0.82, 0.93, 0.86 and 0.92, respectively. Patients PI, P2, and P3, who exhibit a complete or nearcomplete absence of enzyme activity, appear to contain negligible amounts of the tested Complex I subunits in their skeletal muscle mitochondria. Patients P5, P6 and P7, who have moderately or substantially decreased Complex I activities, show a proportional reduction in reactivity of their mitochondrial proteins with all four Complex I sub unit antibodies, whereas they exhibit amounts of ANT and ND5-I cross-reacting protein comparable, e.g., to those of control C4.
Discussion
We have shown that it is possible to raise antibodies successfully against computer-predicted linear epitopes of mitochondrial membrane proteins. Furthermore, these anti bodies were shown to react with the corresponding pro teins not only in immunoprécipitation assays, but also in Western blots. Using the Ribi adjuvant system for immu nization, consistently much lower antibody observed, as compared to the immunizations carried out with the Freund's adjuvant (Table 3) . This phenomenon has previously been observed in rabbits using rat microso mal epoxide hydrolase as an antigen [33] .
Only two of six epitopes of ND4 antibodies positive in both the immunoprecipitation the immunoblot assays. These were the C-terminal (L ) to it. Feamley and an internal Walker [34] predicted that all five internal situated between transmembrane segments. Whether ; are incorrect, or is do not form linear epitopes in the presence of SDS is not clear at Antibodies against internal peptides of ND5 and ND6 reacted also in both the immunoprecipitation and the im munoblot assays. For ND5, these are the first antibodies reported with this capacity. The previously-tested ND5-N and ND5-C peptide-specific antibodies [8] were not capaof ND5. In immunoblot observed reaction with two bands could be inhibited by preincubation of the ND5-I antibod- ies with its corresponding peptide. The protein corresponddegmdation products. This degradation pheing to the upper, strong band is most likely ND5, because nomenon has been previously observed by Robinson [35] . it has the expected molecular mass, as estimated relative to A generalized reduction of immunoreactive Complex I hydrophilic marker proteins, and because it is reduced in subunits has previously been found in mitochondrial myamount in mitochondria from Complex I-deficient patients. opathy patients with a Complex I deficiency by immunoThe lower, weak band may have been produced by a blotting experiments utilizing polyclonal antibodies against reaction with an unknown protein containing a sequence bovine Complex I and antibodies specific for six nuclearhomologous to the ND5-I peptide sequence.
encoded iron-sullur proteins [1, 6] . However, the mtDNAIn the exponential gradient gel system used here, the encoded subunits were not identified in these experiments. ND6 subunit migrated as a doublet band, possibly resulting Therefore, the present work provides the first evidence of a from an unknown post-translational modification of a fracdecrease in the latter subunits in mitochondria of myopation of the protein molecules. The immunoprecipitated thy patients. It was found here that the remaining amount ND6 also appeared as a doublet. In electrophoretic runs of of reacting subunits correlated with the residual Complex I proteins from in isolated HeLa cell mitochondria and of fibroblast whole-cell extracts, ND6 has always been found to migrate as a doublet, making the possibility of prote olytic degradation as the cause of the doublet formation less likely (H. Bentlage, unpublished observations). Also in 20 cm long 16.5% acrylamide gels using the Tricine buffer system [28] ND6 appeared as a doublet band (re sults not shown). The strong immunoprécipitation reaction of the ND6-I3 antibodies, as compared to the ND6-I, antibodies, can be explained by a difference in either the titer or affinity of the two types of antibodies. The nature of the difference was not further investigated. In the Western blotting experiments, ND6 appeared as a single band, probably because of a different size (8 cm) of the gel system used.
In the immunoblots, it was essential to use y-globulin fractions depleted of antibodies to the carrier proteins in order to reduce the background. The remaining back ground could be partially explained by the presence of biotin-containing proteins in skeletal muscle mitochondria. A lower background appeared in the immunoprécipitation assays, since only 13 proteins were labeled that could give rise to non-specific signals.
The antibodies produced in the present work and other subunit-or holoenzyme-specific antibodies were used to investigate the presence and amount of mtDNA-and nuclear-encoded subunits of the respiratory NADH dehydrogenase in the skeletal muscle of by myopathies associated with a Complex I deficiency. The results obtained indicated lower levels of the mtDNA-encoded subunits (ND4, ND5 and ND6) and one nuclear encoded subunit (24 kDa) in all seven patients studied. Also ND1 and several other nuclear encoded subunits were found to be less abundant in five patients studied, when ND1 peptide-specific and Complex I holoenzyme-specific antibodies, respectively, were used. The latter antibodies gave a reaction, in the samples from patients, with two bands that were either not present (20 kDa) or less strongly represented (24 kDa) in the samples from control individuals. The band that migrated with an apparent molecular weight of 24 kDa in the samples from patients (Fig. 4) was shown not to react with 24 kDa subuniKspecific antibodies (Fig. 5) . Both bands probably activity in the skeletal muscle mitochondria
In the case of the two MELAS patients (P5 and P7), a rate of mitochondrial protein synthesis [36, 37] would account for the reduced amount of mitochondrial translation products and a resulting decreased assembly of I. In the other patients, the underlying defect could again be a reduced protein synthetic capacity, or a disturbed assembly and subsequent degradation of Com plex I subunits. The latter process has been shown to occur in a HeLa cell mutant lacking the ND4 subunit [38] . Whether this pathogenetic mechanism operates in any of our patients remains to be determined. The antibodies described here will be useful for identifying defects in biosynthesis or stability of subunits encoded in mtDNA.
